| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Kwang Hyun Ko | |
| Ki Baik Hahm | |||
| Eun-Hee Kim | |||
| Na Young Han | |||
| Young-Min Han | |||
| Jong-Min Park | |||
| Mi Kyung Chung | |||
| Hoo Keun Lee | |||
| P2860 | cites work | From genetics of inflammatory bowel disease towards mechanistic insights | Q26824328 |
| Udp-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancer | Q28392741 | ||
| Unravelling the pathogenesis of inflammatory bowel disease | Q29547551 | ||
| What is the most effective way to communicate results after endoscopy? | Q30483507 | ||
| Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in clinical chemistry | Q31014825 | ||
| Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis | Q31137034 | ||
| Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis. | Q33231216 | ||
| A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry | Q33266200 | ||
| Comparative proteomics and molecular mechanical analysis in CDA-II induced therapy of LCI-D20 hepatocellular carcinoma model | Q33375759 | ||
| SELDI-TOF serum proteomics and colorectal cancer: a current overview | Q33628047 | ||
| Novel polysome messages and changes in translational activity appear after induction of adipogenesis in 3T3-L1 cells | Q34204769 | ||
| Inflammatory bowel disease and colon cancer | Q34206494 | ||
| Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis | Q34654055 | ||
| Comprehensive identification of proteins from MALDI imaging | Q34778073 | ||
| Chemistry meets biology in colitis-associated carcinogenesis | Q35047726 | ||
| Application of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Imaging Mass Spectrometry (MALDI-TOF IMS) for Premalignant Gastrointestinal Lesions | Q35068096 | ||
| The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study | Q35166994 | ||
| Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis | Q35597680 | ||
| The fundamental basis of inflammatory bowel disease | Q35649436 | ||
| Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation | Q35803526 | ||
| Biomarkers in inflammatory bowel disease: current practices and recent advances | Q35840853 | ||
| Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? | Q36144484 | ||
| The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome | Q36462611 | ||
| Inflammation and colorectal cancer: colitis-associated neoplasia | Q36597803 | ||
| Diagnostics of inflammatory bowel disease | Q36993565 | ||
| Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis | Q37098695 | ||
| Colorectal cancer surveillance in inflammatory bowel disease: the search continues | Q37122138 | ||
| Applications of proteomics in the study of inflammatory bowel diseases: Current status and future directions with available technologies | Q37155926 | ||
| The genetics and immunopathogenesis of inflammatory bowel disease | Q37171800 | ||
| Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer | Q37464715 | ||
| Inflammation and colorectal cancer | Q37546461 | ||
| Inflammatory bowel diseases: controversies in the use of diagnostic procedures | Q37604743 | ||
| UDP-glucose dehydrogenase: structure and function of a potential drug target | Q37791597 | ||
| Proteomics technologies for the global identification and quantification of proteins | Q37812484 | ||
| Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications | Q37851008 | ||
| Intestinal inflammation and cancer | Q37870432 | ||
| The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease | Q37870433 | ||
| Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis. | Q37885729 | ||
| Inflammation, DNA methylation and colitis-associated cancer | Q37974887 | ||
| 8-Hydroxydeoxyguanosine: not mere biomarker for oxidative stress, but remedy for oxidative stress-implicated gastrointestinal diseases | Q37980433 | ||
| Fecal lactoferrin as a noninvasive biomarker in inflammatory bowel diseases | Q37989950 | ||
| Fecal markers: calprotectin and lactoferrin | Q38002436 | ||
| Current advantages in the application of proteomics in inflammatory bowel disease | Q38022190 | ||
| The gut microbiota in IBD. | Q38036078 | ||
| Advanced precancerous lesions within the GI tract: the molecular background. | Q38117755 | ||
| Towards personalized care in IBD. | Q38171924 | ||
| Characterization of the interaction of calcyclin (S100A6) and calcyclin-binding protein. | Q38310724 | ||
| MHC Class II alleles in ulcerative colitis-associated colorectal cancer | Q38422582 | ||
| S100A6 is transcriptionally regulated by β-catenin and interacts with a novel target, lamin A/C, in colorectal cancer cells | Q39353517 | ||
| Down-regulation of UDP-glucose dehydrogenase affects glycosaminoglycans synthesis and motility in HCT-8 colorectal carcinoma cells | Q39670211 | ||
| Predicting ulcerative colitis-associated colorectal cancer using reverse-transcription polymerase chain reaction analysis. | Q39715268 | ||
| Specific expression of osteopontin and S100A6 in hepatocellular carcinoma | Q39784164 | ||
| High expression of HSP47 in ulcerative colitis-associated carcinomas: proteomic approach | Q39825248 | ||
| Androgen-stimulated UDP-glucose dehydrogenase expression limits prostate androgen availability without impacting hyaluronan levels | Q39879669 | ||
| Colon cancer in inflammatory bowel disease: recent trends, questions and answers. | Q39904958 | ||
| Biological markers in inflammatory bowel disease: practical consideration for clinicians. | Q39904967 | ||
| Resistance of MLL-AFF1-positive acute lymphoblastic leukemia to tumor necrosis factor-alpha is mediated by S100A6 upregulation | Q40350461 | ||
| Inhibition of human UDP-glucose dehydrogenase expression using siRNA expression vector in breast cancer cells | Q40374362 | ||
| Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers | Q40507334 | ||
| Volatile sulfur compounds as a predictor for esophagogastroduodenal mucosal injury | Q40606155 | ||
| Correlation of CCL20 expression in rectal mucosa with the development of ulcerative colitis-associated neoplasia | Q41912959 | ||
| Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer | Q42152237 | ||
| The role of S100 genes in breast cancer progression | Q42481244 | ||
| Novel application of proton pump inhibitor for the prevention of colitis-induced colorectal carcinogenesis beyond acid suppression | Q42971385 | ||
| Utility of serological markers in inflammatory bowel diseases: gadget or magic? | Q43135089 | ||
| Label-free quantification for discovering novel biomarkers in the diagnosis and assessment of disease activity in inflammatory bowel disease | Q43497860 | ||
| Molecular profiling of ulcerative colitis-associated neoplastic progression | Q44067993 | ||
| Determination and validation of reference gene stability for qPCR analysis in polysaccharide hydrogel-based 3D chondrocytes and mesenchymal stem cell cultural models. | Q44781197 | ||
| Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease | Q45294846 | ||
| Altered expression of MUTYH and an increase in 8-hydroxydeoxyguanosine are early events in ulcerative colitis-associated carcinogenesis. | Q45991000 | ||
| Analyzing S100A6 expression in endoscopic ultrasonography-guided fine-needle aspiration specimens: a promising diagnostic method of pancreatic cancer | Q47233666 | ||
| Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma. | Q53081345 | ||
| Quantitative proteomic approaches in biomarker discovery of inflammatory bowel disease. | Q53264356 | ||
| Cytokeratin 7/20 and mucin core protein expression in ulcerative colitis-associated colorectal neoplasms. | Q53347521 | ||
| Expression of activation-induced cytidine deaminase in ulcerative colitis-associated carcinogenesis. | Q54341973 | ||
| Prevention of Colitis-Associated Carcinogenesis with Infliximab | Q54414113 | ||
| Papel de los marcadores biológicos en la enfermedad inflamatoria intestinal | Q59509646 | ||
| Carcinogenesis in inflammatory bowel disease | Q81164426 | ||
| Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices | Q81397176 | ||
| Ulcerative colitis-associated colorectal cancer is frequently associated with the microsatellite instability pathway | Q81436373 | ||
| Increased expression of DNA methyltransferase-1 in non-neoplastic epithelium helps predict colorectal neoplasia risk in ulcerative colitis | Q84501406 | ||
| Molecular imaging by mass spectrometry--looking beyond classical histology | Q84764449 | ||
| Identification of patients with developing ulcerative colitis-associated neoplasia by nitrative DNA damage marker 8-nitroguanin expression in rectal mucosa | Q86694326 | ||
| P433 | issue | 37 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| inflammatory bowel diseases | Q917447 | ||
| P304 | page(s) | 13466-12476 | |
| P577 | publication date | 2014-10-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: where are we now in the era of the next generation proteomics? | |
| P478 | volume | 20 |
| Q36562047 | Linking estrogen receptor β expression with inflammatory bowel disease activity |
| Q38587041 | Nanoparticle-based imaging of inflammatory bowel disease |
| Q40739614 | Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC |
| Q38600839 | The Proteome of Ulcerative Colitis in Colon Biopsies from Adults - Optimized Sample Preparation and Comparison with Healthy Controls |
Search more.